Matches 1 - 50 out of 133 1 2 3 >


Match Document Document Title
US20140032127 SPECTROSCOPIC FINGER-PRINTING OF RAW MATERIALS  
The invention provides a method for the selection of cultivation component batches to be used in the cultivation of a mammalian cell expressing a protein of interest wherein at least two different...
US20130011834 MEAN DNA COPY NUMBER OF CHROMOSOMAL REGIONS IS OF PROGNOSTIC SIGNIFICANCE IN CANCER  
Methods for predicting a disease free time interval (DFI) for a cancer patient under consideration for initial or further chemotherapy treatment are disclosed. The methods include obtaining a...
US20130046482 SYSTEM AND METHOD FOR ASSOCIATING A MODULI SPACE WITH A MOLECULE  
The present invention relates to a system and a method for constructing and associating a moduli space to a molecule or a model of a molecule. This mathematical representation of molecular...
US20130096846 AUTOMATED BLOOD ANALYZER  
A computer-based method for automatically determining total body albumin of a living being based on the calculated intravascular albumin, the calculated observed ratio of amount of albumin in the...
US20120046962 SYSTEM AND METHOD FOR GLUCOSE MONITORING AND ANALYSIS  
Methods, systems, and computer program products for analyzing glucose levels are disclosed. In an aspect, a method for analyzing glucose levels includes receiving a plurality of glucose levels,...
US20130211731 MULTI-PATIENT DATA COLLECTION, ANALYSIS AND FEEDBACK  
An automated method adapted to monitor and analyze patient data includes: receiving patient data from a set of patient monitoring devices; analyzing the patient data based at least partly on a set...
US20130244892 Risk Factors and Prediction of Adverse Events  
Biomarkers, methods, systems, and related teachings are disclosed for diagnosing the risk of an adverse event in a human, where the adverse event can be unstable angina, ischemic stroke,...
US20150260631 SYSTEM AND METHOD FOR ASSESSING QUANITITES OR SIZES OF LIPOPROTEIN PARTICLES FROM LIPOPROTEIN PARTICLE COMPOSITIONS  
This invention relates to methods for assessing quantities of spherical or substantially spherical lipoprotein particles or portions thereof present in a biological sample based on the measurement...
US20130024130 BLOOD ANALYZER CALIBRATION AND ASSESSMENT  
Systems and methods for displaying measured values of a complete blood count (“CBC”) parameter include displaying the measured values of the CBC parameter obtained from a plurality of samples from...
US20150212091 METHOD FOR CATEGORIZING CIRCULATING TUMOR CELLS  
The present invention provides method for categorizing circulating tumor cells (CTCs) using various cellular markers and revealing or non-revealing assays which provide beneficial insights for...
US20110071768 DEVICE FOR ESTIMATING SURVIVAL CELL COUNT, COMPUTER PROGRAM, AND RECORDING MEDIUM  
By accurately estimating the survival cell count in a probiotic product, the time for developing the product can be shortened. In a device (1) for estimating survival cell count, a calculation...
US20110301864 METHOD OF ASSESSING THE PROLIFERATION OR DIFFERENTIATION BEHAVIOUR OF A POPULATION OF TARGET CELLS IN A BIOLOGICAL SYSTEM  
The invention relates to a method of assessing the proliferation or differentiation behaviour of a population of target cells in a biological system, said method comprising the steps of; [a]...
US20120010824 Non-Invasive Method for Assessing Liver Fibrosis Progression  
The present invention relates to a non-invasive method for assessing liver fibrosis progression in an individual, said method comprising the steps of calculating the ratio of fibrosis level to...
US20130273643 METHODS AND APPARATUSES FOR PREDICTING RISK OF PROSTATE CANCER AND PROSTATE GLAND VOLUME  
Methods and apparatuses for predicting risk of prostate cancer and/or prostate gland volume are provided. More particularly, this disclosure relates to methods and apparatuses for providing the...
US20130158886 Accurate Measurement of glutathione for disease diagnosis and drug metabolite screening  
A method of measuring and calculating (preferably by a computer with output to a user) tGSH (total glutathione very particularly defined) with sample preparation and assay methods that have been...
US20140303228 Biomarkers for Amyotrophic Lateral Sclerosis and Methods Using the Same  
The disclosure provides biomarkers of amyotrophic lateral sclerosis (ALS). The disclosure also provides various methods of using the biomarkers, including methods for diagnosis of ALS, methods of...
US20130260396 HOLOGRAPHIC FLUCTUATION MICROSCOPY APPARATUS AND METHOD FOR DETERMINING MOBILITY OF PARTICLE AND/OR CELL DISPERSIONS  
The present invention relates to an instrument and a measurement apparatus and methodology that yields a measurement and test methodology that characterizes a population of cells/particles or...
US20130245963 SIMPLIFYING RESIDUE RELATIONSHIPS IN PROTEIN DESIGN  
The invention provides a method of determining changes in a first set of residues r1 due to changes in a second set of residues r2 in a protein system comprising one or more proteins comprising n...
US20150233892 WHITE BLOOD CELL MONITORING DURING TREATMENT CYCLES  
This application relates to methods and apparatus for monitoring and predicting a cell count of at least one component of white blood cells, especially absolute neutrophil count (ANC), within a...
US20140287530 LIPOPROTEIN ANALYSIS BY DIFFERENTIAL CHARGED-PARTICLE MOBILITY  
The invention provides methods of preparation of lipoproteins from a biological sample, including HDL, LDL, Lp(a), IDL, and VLDL, for diagnostic purposes utilizing differential charged particle...
US20120178118 BIOMARKERS FOR MONITORING TREATMENT OF NEUROPSYCHIATRIC DISEASES  
Methods for identifying and measuring pharmacodynamic biomarkers of neuropsychiatric disease, and for monitoring a subject's response to treatment.
US20110166794 BLOOD CELL COUNTER, DIAGNOSIS SUPPORT APPARATUS, DIAGNOSIS SUPPORT METHOD AND COMPUTER PROGRAM PRODUCT  
A blood cell counter comprising: a detector for detecting blood cells in blood of a subject; and a controller for obtaining, based on a detection result by the detector, first analytical...
US20110276277 SIZE-BASED GENOMIC ANALYSIS  
Systems, methods, and apparatuses for performing a prenatal diagnosis of a sequence imbalance are provided. A shift (e.g. to a smaller size distribution) can signify an imbalance in certain...
US20120041687 IDENTIFICATION, MONITORING AND TREATMENT OF INFECTIOUS DISEASE AND CHARACTERIZATION OF INFLAMMATORY CONDITIONS RELATED TO INFECTIOUS DISEASE USING GENE EXPRESSION PROFILES  
A method is provided in various embodiments for determining a profile data set for a subject with infectious disease or inflammatory conditions related to infectious disease based on a sample from...
US20110295520 Method and System for Quantitative Cell Nuclei Arrangement Measure in Histological Tissue Using Structural Entropy  
A method for measuring structural entropy of cell nuclei in a histological micrograph of a biopsy tissue sample involves the steps of: obtaining a dye color map from a color image of the biopsy...
US20130303401 SYSTEMS AND METHODS FOR DIAGNOSING RENAL CELL CARCINOMA  
Systems, methods, and computer readable media for diagnosing or characterizing kidney cancer based on serum amino acid profiles are provided. Serum amino acid concentrations, and optionally also...
US20130217028 PERIPHERAL BLOOD GENE MARKERS FOR EARLY DIAGNOSIS OF PARKINSON'S DISEASE  
The present invention relates to the use of molecular risk marker profiles for diagnosis of Parkinson's disease. More particularly, the invention provides methods for diagnosis of Parkinson's...
US20120328606 Methods Of Diagnosing And Treating Pulmonary Diseases Or Disorders  
The present disclosure provides methods of diagnosing a subject as having a pulmonary disease or disorder, e.g., an eosinophilic disease or disorder based on the determination of white blood cell...
US20120191367 ASSAY SYSTEMS FOR DETERMINATION OF FETAL COPY NUMBER VARIATION  
The present invention provides processes for determining accurate risk probabilities for chromosome dosage abnormalities. Specifically, the invention provides non-invasive evaluation of genomic...
US20120173160 METHODS AND SYSTEMS FOR QUANTITATIVELY ASSESSING BIOLOGICAL EVENTS USING ENERGY-PAIRED SCORING  
Methods for quantitatively assessing the status of a biological event in a testing sample comprise computing a pair-wise energy score for each analyte pair for the biological event based on a...
US20130131996 Predictive Test for Selection of Metastatic Breast Cancer Patients for Hormonal and Combination Therapry  
A mass-spectral method is disclosed for determining whether breast cancer patient is likely to benefit from a combination treatment in the form of administration of a targeted anti-cancer drug in...
US20140343869 PARTICLE PROCESSING SYSTEMS AND METHODS FOR NORMALIZATION/CALIBRATION OF SAME  
Systems, methods and non-transitory storage medium are disclosed herein for adjusting an output of a particle inspection system representative of a particle characteristic for a particle flowing...
US20130297224 Method for evaluating a set of measurement data from an oral glucose tolerance test  
A method is provided for evaluating a set of measurement data from an oral glucose tolerance test. The method may include calculating a similarity measure that quantifies the similarity between a...
US20120190018 ENHANCED RISK PROBABILITIES USING BIOMOLECULE ESTIMATIONS  
The present invention provides processes for determining more accurate risk probabilities for medical conditions. The risk probabilities of the presence or absence of a medical condition are...
US20120065898 AUTOMATIC ANALYZER  
To change a photometric time for each item or to change a measurement time for each specimen so that time required for biochemical measurement can be reduced, an index that indicates an end of a...
US20120078531 FLUIDIC FLOW CYTOMETRY DEVICES AND PARTICLE SENSING BASED ON SIGNAL-ENCODING  
Microfluidic devices, systems and techniques in connection with particle sorting in liquid, including cytometry devices and techniques and applications in chemical or biological testing and...
US20090287421 Enhancing Flow Cytometry Discrimination with Geometric Transformation  
In flow cytometry, particles (2) can be distinguished between populations (8) by combining n-dimensional parameter data, which may be derived from signal data from a particle, to mathematically...
US20130018596 METHOD AND DEVICE FOR DETERMINING TARGET BRAIN SEGMENTS IN HUMAN OR ANIMAL BRAINS  
Method and device for determining target brain segments in human or animal brains An embodiment of the invention relates to a method for determining at least one target brain segment of a human or...
US20130030715 APPARATUS AND METHOD FOR MONITORING AUTOTROPH CULTIVATION  
A method includes identifying a chlorophyll concentration/optical density (CCpOD) value using a chlorophyll concentration measurement of an autotroph culture and an optical density measurement of...
US20120101740 METHOD, INSTRUMENT AND COMPUTER PROGRAM PRODUCT FOR QUANTIFICATION OF PCR PRODUCTS  
This document relates to melting curve analysis of nucleic acids. The method according to first aspect of the invention comprises analyzing a nucleic acid melting curve measured from a sample, the...
US20090006003 SAMPLE ANALYZER, BLOOD ANALYZER AND DISPLAYING METHOD  
The present invention is to present a sample analyzer which is capable of displaying a particle distribution map of a measured sample and a reference particle distribution map so as to be visually...
US20130022991 CELL FREE CD4 QUANTITATION AND METHODS OF USE  
The present invention provides a low-cost cell-free assay, the α-test, that provides point-of-care CD4 enumeration using a single platform assay thereby eliminating the need for high-end...
US20080189050 Process Of Statistic Validation Of Corneal Endothelial Cells Analysed Samples  
Process of statistic validation of corneal endothelial cells analysed samples”, refers to a process complementary to the conventional process known as cornea specular microscopy, by incorporating...
US20090093970 Automated Sampling And Analysis Using A Personal Sampler Device  
The present invention is a system and a method for blood or urine sampling and sample-analysis, through a sampler that is a self blood-testing device or a urine-testing device. The system...
US20140186874 IMMATURE PLATELET ENUMERATION SYSTEMS AND METHODS  
Embodiments of the present invention encompass automated systems and methods for analyzing immature platelet parameters in an individual based on a biological sample obtained from blood of the...
US20120101738 Compositions and methods for biological remodeling with frozen particle compositions  
Certain embodiments disclosed herein relate to compositions, methods, devices, systems, and products regarding frozen particles. In certain embodiments, the frozen particles include materials at...
US20130282301 Closed Loop Blood Glucose Control Algorithm Analysis  
Methods and devices to generate a tool for testing, simulating and/or modifying a closed loop control algorithm are provided. Embodiments include receiving glucose data for a predetermined time...
US20130345989 METHOD AND DEVICE FOR COUNTING PARTICLES IN LIQUID  
For a blood cell measuring part replaceably formed as a cartridge, a threshold value for determining particles is adjusted utilizing a specific parameter that observably varies according to the...
US20130297222 METHOD AND APPARATUS FOR ANALYTE MEASUREMENTS USING CALIBRATION SETS  
Examples of methods and apparatus are described that permit an analyte concentration to be estimated from a measurement in the presence of compounds that interfere with the measurement. In one...
US20150160115 NEIGHBORHOOD THRESHOLDING IN MIXED MODEL DENSITY GATING  
The present invention provides automatic gating methods that are useful to gate populations of interest in multidimensional data, wherein the populations of interest are only a subset of the...

Matches 1 - 50 out of 133 1 2 3 >